RECENT TRANSACTIONS

 

 

Dipexium Pharmaceuticals Inc. announces the closing of its initial public offering of about 3.16 million shares of its common stock at a public offering price of $12.00 per share

Ruthigen Inc Announces Initial Public Offering-Form S-1/A

 

Liver disease biotech Galmed files for a $35 million IPO

 

 

Cancer diagnostics and therapeutics company Microlin Bio files for

a $25 million IPO

Tonix Pharmaceuticals

(NASDAQ: TNXP)

Announces Closing of Public Offering

Heat Bio's (NASDAQ: HTBX)

IPO haul stands at $26M following over allotment

China Commercial Credit

 (NASDAQ: CCCR) Prices Initial Public Offering; Begins Trading

Organovo Holdings

(NYSE MKT: ONVO)

Closes $46.6 Million Public Offering of Common Stock

Matinas BioPharma Inc. is a privately-held biopharmaceutical company

Intercept Pharmaceuticals

Intercept Pharmaceuticals Announces Completion of Public Offering and Exercise of Option to Purchase Additional Shares

©2017 All Rights Reserved V Stock Transfer, LLC     Disclaimer

Design by GraphicIQ

212.828.8436

Toll Free: 855.9VSTOCK